Identification and characterization of a bioactive lantibiotic produced by Staphylococcus warneri

Biological Chemistry

Volumn 390, Issue 5-6, 2009, Pages 437-444

  Petersen, Jørgen ^a,b   Boysen, Anders ^a   Fogh, Lotte ^a   Tabermann, Kathrine ^a   Kofoed, Thomas ^a   King, Angus ^a   Schrotz King, Petra ^a   Hansen, Martin Christian ^a  

^a ACE BioSciences AS   (Denmark)

^b DANISH TECHNOLOGICAL INSTITUTE   (Denmark)

Author keywords

Electrospray ionization mass spectrometry (ESI MS); Lantibiotic; Matrix assisted laser desorption ionization time of flight mass spectrometry (MALDI TOF MS); Staphylococcus warneri

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; AMINO ACID; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DIDEHYDROALANINE; DIDEHYDROAMINOBUTYRIC ACID DERIVATIVE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LANTHIONINE; LANTIBIOTIC; METHYLLANTHIONINE; NATURAL PRODUCT; OFLOXACIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; STAPHYLOCOCCUS WARNERI LANTIBIOTIC PEPTIDE 1; SULFIDE; SULTAMICILLIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; DRUG MANUFACTURE; ELECTROSPRAY MASS SPECTROMETRY; GRAM POSITIVE BACTERIUM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SECRETION; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS WARNERI; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIOCINS; ENTEROCOCCUS FAECIUM; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS WARNERI;

EID: 67649599115     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.062     Document Type: Article

References (30)

1. Barigye, R., Schaan, L., Gibbs, P.S., Schamber, E., and Dyer, N.W. (2007). Diagnostic evidence of Staphylococcus warneri as a possible cause of bovine abortion. J. Vet. Diagn. Invest. 19, 694-696.
2. Breukink, E., van Kraaij, C., Demel, R.A., Siezen, R.J., Kuipers, O.P., and de Kruijff, B. (1997). The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 36, 6968-6976.
3. Breukink, E., van Heusden, H.E., Vollmerhaus, P.J., Swiezewska, E., Brunner, L., Walker, S., Heck, A.J., and de Kruijff, B. (2003). Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J. Biol. Chem. 278, 19898-19903.
4. Delves-Broughton, J., Blackburn, P., Evans, R.J., and Hugenholtz, J. (1996). Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek 69, 193-202.
5. Gobom, J., Nordhoff, E., Mirgorodskaya, E., Ekman, R., and Roepstorff, P. (1999). Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrixassisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 34, 105-116.
6. Guder, A., Wiedemann, I., and Sahl, H.G. (2000). Posttranslationally modified bacteriocins - the lantibiotics. Biopolymers 55, 62-73.
7. Hechard, Y., Ferraz, S., Bruneteau, E., Steinert, M., and Berjeaud, J.M. (2005). Isolation and characterization of a Staphylococcus warneri strain producing an anti-Legionella peptide. FEMS Microbiol. Lett. 252, 19-23.
8. Jack, R.W. and Sahl, H.G. (1995). Unique peptide modifications involved in the biosynthesis of lantibiotics. Trends Biotechnol. 13, 269-278.
9. Jack, R., Benz, R., Tagg, J., and Sahl, H.G. (1994). The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur. J. Biochem. 219, 699-705.
10. Kaletta, C., Entian, K.D., Kellner, R., Jung, G., Reis, M., and Sahl, H.G. (1989). Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch. Microbiol. 152, 16-19.
11. Kamath, U., Singer, C., and Isenberg, H.D. (1992). Clinical significance of Staphylococcus warneri bacteremia. J. Clin. Microbiol. 30, 261-264.
12. Krull, R.E., Chen, P., Novak, J., Kirk, M., Barnes, S., Baker, J., Krishna, N.R., and Caufield, P.W. (2000). Biochemical structural analysis of the lantibiotic mutacin II. J. Biol. Chem. 275, 15845-15850.
13. Lian, L.Y., Chan, W.C., Morley, S.D., Roberts, G.C., Bycroft, B.W., and Jackson, D. (1992). Solution structures of nisin A and its two major degradation products determined by NMR. Biochem. J. 283, 413-420.
14. Martin, N.I., Sprules, T., Carpenter, M.R., Cotter, P.D., Hill, C., Ross, R.P., and Vederas, J.C. (2004). Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry 43, 3049-3056.
15. Meyer, H.E., Heber, M., Eisermann, B., Korte, H., Metzger, J.W., and Jung, G. (1994). Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation. Anal. Biochem. 223, 185-190.
16. Minamikawa, M., Kawai, Y., Inoue, N., and Yamazaki, K. (2005). Purification and characterization of Warnericin RB4, anti- Alicyclobacillus bacteriocin, produced by Staphylococcus warneri RB4. Curr. Microbiol. 51, 22-26.
17. Moll, G.N., Roberts, G.C., Konings, W.N., and Driessen, A.J. (1996). Mechanism of lantibiotic-induced pore-formation. Int. J. Gen. Mol. Microbiol. 69, 185-191.
18. Nissen-Meyer, J. and Nes, I.F. (1997). Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action. Arch. Microbiol. 167, 67-77.
19. Rayman, M.K., Aris, B., and Hurst, A. (1981). Nisin: a possible alternative or adjunct to nitrite in the preservation of meats. Appl. Environ. Microbiol. 41, 375-380.
20. Ross, K.F., Ronson, C.W., and Tagg, J.R. (1993). Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl. Environ. Microbiol. 59, 2014-2021.
21. Sahl, H.G., Jack, R.W., and Bierbaum, G. (1995). Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur. J. Biochem. 230, 827-853.
22. Saris, P.E., Immonen, T., Reis, M., and Sahl, H.G. (1996). Immunity to lantibiotics. Antonie Van Leeuwenhoek 69, 151-159.
23. Sashihara, T., Kimura, H., Higuchi, T., Adachi, A., Matsusaki, H., Sonomoto, K., and Ishizaki, A. (2000). A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure. Biosci. Biotechnol. Biochem. 64, 2420-2428.
24. Schuller, F., Benz, R., and Sahl, H.G. (1989). The peptide antibiotic subtilin acts by formation of voltage-dependent multistate pores in bacterial and artificial membranes. Eur. J. Biochem. 182, 181-186.
25. Smith, L., Novak, J., Rocca, J., McClung, S., Hillman, J.D., and Edison, A.S. (2000). Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics. Eur. J. Biochem. 267, 6810-6816.
26. van Belkum, M.J. and Stiles, M.E. (2000). Nonlantibiotic antibacterial peptides from lactic acid bacteria. Nat. Prod. Rep. 17, 323-335.
27. van de Kamp, M., Horstink, L.M., van den Hooven, H.W., Konings, R.N., Hilbers, C.W., Frey, A., Sahl, H.G., Metzger, J.W., and van de Ven, F.J. (1995a). Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Eur. J. Biochem. 227, 757-771.
28. van de Kamp, M., van den Hooven, H.W., Konings, R.N., Bier-baum, G., Sahl, H.G., Kuipers, O.P., Siezen, R.J., de Vos, W.M., Hilbers, C.W., and van de Ven, F.J. (1995b). Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. Eur. J. Biochem. 230, 587-600.
29. Vorm, O., Roepstorff, P., and Mann, M. (1994). Matrix surfaces made by fast evaporation yield improved resolution and very high sensitivity in MALDI TOF. Anal. Chem. 66, 3281-3287.
30. 1H-NMR and 13C-NMR assignments and revised primary structure. Eur. J. Biochem. 228, 786-797.